Cited by 327Blood Pressure and Hypertension StudiesChronic Kidney Disease and DiabetesDiabetes, Cardiovascular Risks, and Lipoproteins

The DOI matches its Crossref record; 135 of the 135 references it cites were found in a registry or an index.

The Treatment of Hypertension in Adult Patients With Diabetes

Open access

Arauz-Pacheco, Carlos, Parrott, Marian A., Raskin, Philip·2002·Diabetes Care

DOI 10.2337/diacare.25.1.134

Open this paper in CoChat — free account Open PDF

Abstract

Hypertension is an extremely common comorbidity of diabetes, affecting 20–60% of people with diabetes. Hypertension is also a major risk factor for cardiovascular events, such as myocardial infarction and stroke, as well as for microvascular complications, such as retinopathy and nephropathy. Cardiovascular disease is the most costly complication of diabetes and is the cause of 86% of deaths in persons with diabetes (1). However, until recently, little research had been done specifically in patients with diabetes and hypertension. In reviewing the literature on diabetes and hypertension, the authors searched MEDLINE for English language articles using keywords “hypertension,” “diabetes mellitus,” “diabetic nephropathy,” and “coronary artery disease/prevention” starting from 1966. Before 1996, most available data come from secondary analysis from studies done in the general population of people with hypertension, observing a subset with diabetes. Recent studies have demonstrated the effectiveness of blood pressure treatment versus placebo in reducing complications of diabetes (2,3), helped to define the optimal level of blood pressure control (4,5,6), and compared treatment strategies based on different drug classes (7,8,9,10,11,12,13). The results of these studies support an aggressive approach to the diagnosis and treatment of hypertension in patients with diabetes in order to substantially reduce the incidence of both macrovascular and microvascular complications. ### Definition of hypertension in diabetic populations Epidemiological studies and therapeutic trials have often used different criteria to define hypertension in diabetic patients. Studies in the general population indicate an increased risk of cardiovascular disease with an increase in the level of blood pressure. Thus, an increase in diastolic or systolic blood pressure of 5 mmHg is associated with a concomitant increase in cardiovascular disease of 20–30% (14). Studies in diabetic populations have shown a markedly higher frequency of the progression of diabetic retinopathy …

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.2337/diacare.25.1.134

Cites

135 of 135 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>
Chobanian, A. V. (2003) · JAMA · doi:10.1001/jama.289.19.2560 · Cited by 25,386
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
Brenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H.-H., Remuzzi, G., Snapinn, S. M., Zhang, Z., & Shahinfar, S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011161 · Cited by 7,493
Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38
(1998) · BMJ · doi:10.1136/bmj.317.7160.703 · Cited by 6,683
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes
Lewis, E. J., Hunsicker, L. G., Clarke, W. R., Berl, T., Pohl, M. A., Lewis, J. B., Ritz, E., Atkins, R. C., Rohde, R., & Raz, I. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011303 · Cited by 5,987
Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the hypertension optimal treatment (HOT) randomised trial
Hansson, L., Zanchetti, A., Carruthers, S. G., Dahlöf, B., Elmfeldt, D., Julius, S., Ménard, J., Rahn, K. H., Wedel, H., & Westerling, S. (1998) · The Lancet · doi:10.1016/s0140-6736(98)04311-6 · Cited by 5,728
The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy
Lewis, E. J., Hunsicker, L. G., Bain, R. P., & Rohde, R. D. (1993) · New England Journal of Medicine · doi:10.1056/nejm199311113292004 · Cited by 5,394
Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38
Stearne, M. R., Palmer, S. L., Hammersley, M. S., Franklin, S. L., Spivey, R. S., Lévy, J., Tidy, C. R., Bell, N. J., Steemson, J., Barrow, B. A., et al. (1998) · UCL Discovery (University College London) · Cited by 4,803
Blood pressure, stroke, and coronary heart disease
Collins, R., Peto, R., MacMahon, S., Godwin, J., Qizilbash, N., Collins, R., MacMahon, S., Hebert, P., Eberlein, K. A., Taylor, J. O., et al. (1990) · The Lancet · doi:10.1016/0140-6736(90)90944-z · Cited by 4,491
Blood pressure, stroke, and coronary heart disease *1Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias
MACMAHON, S. (1990) · The Lancet · doi:10.1016/0140-6736(90)90878-9 · Cited by 4,253 · cited 1×
“Thus, an increase in diastolic or systolic blood pressure of 5 mmHg is associated with a concomitant increase in cardiovascular disease of 20–30% (14).”
Background
The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure
(1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440420033005 · Cited by 3,777

Show all 129 references

Sorted by citations

Items 101–200 of 327

Serum cholesterol and LDL-C in association with level of diastolic blood pressure in type 2 diabetic patients.
Behradmanesh, S., & Nasri, P. (2012) · PubMed Central · doi:10.12861/jrip.2012.09 · Cited by 30
“(1) The research followed the tenets of the Declaration of Helsinki; (2) informed consent was obtained; (3) the research was approved by ethical committee of Shahrekord University of Medical Sciences.”
BackgroundMethodInfluential
Safety and tolerability of duloxetine treatment of diabetic peripheral neuropathic pain between patients with and without cardiovascular conditions
Wernicke, J., Prakash, A., Kajdasz, D. K., & Houston, J. (2008) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2008.07.004 · Cited by 29
Study on Risk Factors of Diabetic Nephropathy in Obese Patients with Type 2 Diabetes Mellitus
Hu, F., & Zhang, T. (2020) · International Journal of General Medicine · doi:10.2147/ijgm.s255858 · Cited by 29
Type 2 diabetes mellitus is associated with multiple cardiometabolic risk factors
Gerich, J. E. (2007) · Clinical cornerstone · doi:10.1016/s1098-3597(07)80028-7 · Cited by 29
Antihypertensive efficacy and safety of a standardized herbal medicinal product of Hibiscus sabdariffa and Olea europaea extracts ( NW Roselle): A phase‐II , randomized, double‐blind, captopril‐controlled clinical trial
Elkafrawy, N., Younes, K., Naguib, A. M., Badr, H. R., Zewain, S. K., Kamel, M. A., Raoof, G. F. A., Eldesoky, A. M., & Mohamed, S. O. (2020) · Phytotherapy Research · doi:10.1002/ptr.6792 · Cited by 28
Choice of anti-hypertensive agents in diabetic subjects
Patel, B. M., & Mehta, A. A. (2013) · Diabetes and Vascular Disease Research · doi:10.1177/1479164113485250 · Cited by 29
The role of glycated hemoglobin (HbA1c) and serum lipid profile measurements to detect cardiovascular diseases in type 2 diabetic patients
Naeem, M. T., Khattak, R. M., Rehman, M. U., & Khattak, M. N. K. (2016) · South East Asia Journal of Public Health · doi:10.3329/seajph.v5i2.28310 · Cited by 28
“It affects 40-60% of DM patients.(3-4) Similarly obesity is considered a risk factor for insulin resistance, cardiovascular and related diseases.”
Drug Compliance Among Hypertensive Patients; an Area Based Study
Al-Mehza, A. M., Al-Muhailije, F. A., Khalfan, M. M., & Al-Yahya, A. A. (2009) · Electronic Journal of General Medicine · doi:10.29333/ejgm/82628 · Cited by 27
Distorted Self-Perceived Weight Status and Underestimation of Weight Status in Diabetes Mellitus Type 2 Patients
Mogre, V., Abedandi, R., & Salifu, Z. S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095165 · Cited by 27
“Hypertension and diabetes mellitus coexist in approximately 40% to 60% in patients with DM 2 [37,38,39].”
Background
What Should Be the Target Blood Pressure in Elderly Patients With Diabetes?
Solini, A., & Grossman, E. (2016) · Diabetes Care · doi:10.2337/dcs15-3027 · Cited by 27
“130/80 mmHg are already defined as hypertension (6).”
Background
Diabetes Mellitus and Heart Failure
Sander, G. E., & Giles, T. D. (2003) · The American Heart Hospital Journal · doi:10.1111/j.1541-9215.2003.02085.x · Cited by 27
The Blood Pressure "Uncertainty Range" – a pragmatic approach to overcome current diagnostic uncertainties (II)
Pater, C. (2005) · Current Controlled Trials in Cardiovascular Medicine · doi:10.1186/1468-6708-6-5 · Cited by 27
“Given the widespread consensus that patients with diabetes and associated hypertension should get pharmacological treatment whenever BP > 130/80 mmHg [42,43], the two distributions do not appear to have any degree of overlap, with the cut-off point of 130/80 mmHg discriminating well between those supposed to be treate…”
Background
Prevalence of diabetic nephropathy in primary care type 2 diabetic patients with hypertension: data from the Korean Epidemiology Study on Hypertension III (KEY III study)
Yang, C. W., Park, J. T., Kim, Y. S., Kim, Y. L., Lee, Y.-S., Oh, Y.-S., & Kang, S. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr011 · Cited by 27
“5–3 times higher than in the age-matched nondiabetic population [3, 4].”
Background
Normotensive Women With Type 2 Diabetes and Microalbuminuria Are at High Risk for Macrovascular Disease
Zandbergen, A. A. M., Sijbrands, E. J. G., Lamberts, S. W. J., & Bootsma, A. H. (2006) · Diabetes Care · doi:10.2337/dc06-0287 · Cited by 26
“The current definition of normotension is blood pressure 140/90 mmHg, with a blood pressure–lowering target 130/80 mmHg in adults with diabetes (10,11).”
Background
Differential expression of neuregulin-1 isoforms and downregulation of erbin are associated with Erb B2 receptor activation in diabetic peripheral neuropathy
Pan, P., & Dobrowsky, R. T. (2013) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-1-39 · Cited by 27
“The ADA recommends controlling blood pressure to less than 130/80 mm Hg in diabetic patients [118].”
Predictors of Blood Pressure Response to Angiotensin Receptor Blocker/Diuretic Combination Therapy: A Secondary Analysis of the Irbesartan/Hydrochlorothiazide Blood Pressure Reductions in Diverse Patient Populations (INCLUSIVE) Study
Saunders, E., Cable, G., & Neutel, J. (2008) · Journal of Clinical Hypertension · doi:10.1111/j.1524-6175.2007.07195.x · Cited by 26
Treatment and control of blood pressure in patients with diabetes mellitus
Choe, H. M., Townsend, K., Blount, G., Lo, C. H., Sadowski, L., & Standiford, C. J. (2006) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp060061 · Cited by 26
Sasang constitution may act as a risk factor for prehypertension
Jang, E., Baek, Y., Kim, Y., Park, K., & Lee, S. (2015) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-015-0754-9 · Cited by 25
“Background Hypertension (HTN) is one of main risk factors for cardiovascular diseases, such as myocardial infarction, stroke, and heart failure, which increase both mortality and morbidity [1, 2].”
Background
Association of serum lipids with level of blood pressure in type 2 diabetic patients.
Nasri, H., Behradmanesh, S., Ahmadi, A., Baradaran, A., Nasri, P., & Rafieian‐Kopaei, M. (2014) · PubMed Central · doi:10.12861/jrip.2014.15 · Cited by 25
Physician adherence to hypertension treatment guidelines and drug acquisition costs of antihypertensive drugs at the cardiac clinic: a pilot study
Abdulameer, S. A., Sahib, M. N., Aziz, A., Hassan, Alrazzaq, A., & Ismail (2012) · Patient Preference and Adherence · doi:10.2147/ppa.s27223 · Cited by 25
A Comparison of Service Use and Costs Among Adults With ADHD and Adults With Other Chronic Diseases
Hinnenthal, J. A., Perwien, A. R., & Sterling, K. L. (2005) · Psychiatric Services · doi:10.1176/appi.ps.56.12.1593 · Cited by 25
Blood pressure control, hypertension, awareness, and treatment in adults with diabetes in the United States-Mexico border region
Vijayaraghavan, M., He, G., Stoddard, P. J., & Schillinger, D. (2010) · Revista Panamericana de Salud Pública · doi:10.1590/s1020-49892010000900006 · Cited by 25
Blood Pressure Management in Patients With Diabetes
Salanitro, A. H., & Roumie, C. L. (2010) · Clinical Diabetes · doi:10.2337/diaclin.28.3.107 · Cited by 25
Modifications of Coronary Risk Factors
Albu, J., Gottlieb, S. H., August, P., Nesto, R. W., & Orchard, T. J. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.03.012 · Cited by 24
A computational framework to identify patients with poor adherence to blood pressure lowering medication
Mabotuwana, T., Warren, J., & Kennelly, J. (2009) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2009.06.006 · Cited by 23
“with diabetes and hypertension [23].”
Seasonal Variation in Blood Pressure in 162,135 Patients With Type 1 or Type 2 Diabetes Mellitus
Hermann, J. M., Rosenbauer, J., Dost, A., Steigleder‐Schweiger, C., Kieß, W., Schöfl, C., Holl, R. W., & Initiative, T. D. (2015) · Journal of Clinical Hypertension · doi:10.1111/jch.12743 · Cited by 23
“Depending on age, 20% to 60% of T2DM patients and up to 30% of T1DM patients are affected by hypertension.(1) Since high blood pressure (BP) is one of the main risk factors for cardiovascular events and microvascular complications,(1) current European guidelines (2013 European Society of Hypertension/European Society…”
Background
Complications of Diabetes Mellitus
Sen, S., Chakraborty, R., & De, B. (2016) · Springer eBooks · doi:10.1007/978-981-10-1542-7_8 · Cited by 21
Effects of an olmesartan medoxomil based treatment algorithm on 24-hour blood pressure control in patients with hypertension and type 2 diabetes
Neutel, J. M., Kereiakes, D. J., Waverczak, W. F., Stoakes, K. A., Xu, J., & Shojaee, A. (2010) · Current Medical Research and Opinion · doi:10.1185/03007990903553556 · Cited by 20
Chapter 4: Blood pressure management in CKD ND patients with diabetes mellitus
(2012) · Kidney International Supplements · doi:10.1038/kisup.2012.54 · Cited by 21
Antihypertensive Treatment and Resistant Hypertension in Patients With Type 1 Diabetes by Stages of Diabetic Nephropathy
Lithovius, R., Harjutsalo, V., Forsblom, C. M., Saraheimo, M., Groop, P., & on behalf of the FinnDiane Study Group (2013) · Diabetes Care · doi:10.2337/dc13-2023 · Cited by 21
Development and Validation of a Model That Predicts the Risk of Diabetic Nephropathy in Type 2 Diabetes Mellitus Patients: A Cross-Sectional Study
Yang, J., & Jiang, S. (2022) · International Journal of General Medicine · doi:10.2147/ijgm.s363474 · Cited by 21
“5–3 times the prevalence of hypertension than their age-matched nontype 2 diabetic counterparts.(34) In our study, 56.”
Background
El patrón de prescripción de los fármacos antihipertensivos en los pacientes diabéticos de la Provincia del Sur, Reino de Arabia Saudita
Alavudeen, S. S., Alakhali, K. M., Ansari, S. M. A., & Khan, N. A. (2015) · Ars Pharmaceutica (Internet) · doi:10.4321/s2340-98942015000200005 · Cited by 19
Cost-Effectiveness of Irbesartan 300 mg Given Early Versus Late in Patients with Hypertension and a History of Type 2 Diabetes and Renal Disease: A Canadian Perspective
Coyle, D., Rodby, R. A., Soroka, S., Levin, A., Muirhead, N., de Cotret, P. R., Chen, R. K., & Palmer, A. J. (2007) · Clinical Therapeutics · doi:10.1016/j.clinthera.2007.07.029 · Cited by 19
Lipospheres for Simultaneous Controlled Release and Improved Pharmacokinetic Profiles of Saxagliptin-Enalapril: Formulation, Optimization, and Comparative In Vitro-In Vivo Evaluation
Maheen, S., Rasul, A., Hanif, M., & Khan, H. U. (2020) · AAPS PharmSciTech · doi:10.1208/s12249-020-01733-w · Cited by 18
“So, enalapril (EP) being an ACE inhibitor is being considered for treating hypertension in diabetic conditions (6,7).”
Background
Pattern of anti-diabetic drugs prescribed in a tertiary care hospital of Bangladesh
Ahmed, Z., Hafez, M., Bari, M. A., & Akhter, J. (2016) · International Journal of Basic & Clinical Pharmacology · doi:10.18203/2319-2003.ijbcp20160079 · Cited by 18
Prevalence and associated risk factors of undiagnosed diabetes among adult Moroccan Sahraoui women
Rguibi, M. A., & Belahsen, R. (2006) · Public Health Nutrition · doi:10.1079/phn2005866 · Cited by 19
Non-achievement of clinical targets in patients with type 2 diabetes mellitus.
Eid, M., Mafauzy, M., & Faridah, A. R. (2004) · PubMed · Cited by 18
Effect of nebivolol and metoprolol treatments on serum asymmetric dimethylarginine levels in hypertensive patients with type 2 diabetes mellitus.
Oğuz, A., Uzunlulu, M., Yorulmaz, E., Yalçın, Y., Hekim, N., & Fıcı, F. (2007) · PubMed · Cited by 18
Diabetes‐Related Risk Factors Across Hispanic Subgroups in the Hispanic Health and Nutritional Examination Survey (1982–1984)
Aponte, J. (2008) · Public Health Nursing · doi:10.1111/j.1525-1446.2008.00741.x · Cited by 17
Blood Pressure Control in Hypertensive Patients in Federally Qualified Health Centers
Olomu, A. B., Khan, N. N. S., Todem, D., Huang, Q., Bottu, S., Qadri, S. S., & Holmes-Rovner, M. M. (2016) · MDM Policy & Practice · doi:10.1177/2381468316656010 · Cited by 17
“The prevalence of HTN among people with diabetes is very high, and its presence doubles the risk of cardiovascular diseases.(4) HTN substantially contributes to morbidity and mortality by increasing the risk of both macrovascular and microvascular complications, including stroke, coronary heart disease (CHD), cardiomy…”
Background
Blood Pressure Control among Hypertensive Diabetic Patients on Follow‐Up at Chronic Clinic of Nekemte Referral Hospital in West Ethiopia
Dedefo, M. G., Gemechu, D. B., Fekadu, G., & Dibessa, T. T. (2020) · International Journal of Hypertension · doi:10.1155/2020/7526257 · Cited by 16
“5 to three times more common in patients with diabetes than in those who do not have the disease [5, 10].”
Background
Study of utilization pattern of anti-hypertensive drugs in hypertensive diabetic patients with or without reduced renal function at tertiary care teaching hospital
Shah, J., Khakhkhar, T. M., Bhirud, S., Shah, R., & Date, S. (2012) · International Journal of Medical Science and Public Health · doi:10.5455/ijmsph.2013.2.167-172 · Cited by 16
“Hypertension affects about 20-60% of patients with type-2 diabetes.[1] Serious cardiovascular events are more than twice likely in patients with diabetes and hypertension than either disease alone.”
Background
Relationship Between Low-Normal Blood Pressure and Kidney Disease in Type 1 Diabetes
Shankar, A., Klein, R., Klein, R., Nieto, F. J., & Moss, S. E. (2006) · Hypertension · doi:10.1161/01.hyp.0000252431.75154.3a · Cited by 16
“Systolic BP 120 mm Hg and diastolic BP 70 mm Hg 44 (8) 0.”
Background
The dietitians challenge: the implementation of nutritional advice for people with diabetes*
Nutrition Sub-Committee of the Diabetes Care Advisory Committee of Diabetes UK (2003) · Journal of Human Nutrition and Dietetics · doi:10.1046/j.1365-277x.2003.00460.x · Cited by 17
Hypertension and diabetes in Detroit Hispanics
Artinian, N. T., Nies, M. A., Schim, S. M., Wal, J. S. V., & Keves-Foster, M. K. (2004) · Applied Nursing Research · doi:10.1016/j.apnr.2004.06.010 · Cited by 16
Management of Hypertension in Patients with Type 2 Diabetes Mellitus: Indian Guideline 2024 by Association of Physicians of India and Indian College of Physicians
Wander, G. S., Panda, J. K., Pal, J., Mathur, G., Sahay, R. K., TIWASKAR, M. H., Chatterjee, N., Chakrabarty, S., Singh, D. P., Murthy, L. S., et al. (2024) · Journal of the Association of Physicians of India · doi:10.59556/japi.72.0620 · Cited by 16
“23 Type 2 diabetes mellitus and hypertension have interrelated pathways such as oxidative stress, the renin–angiotensin– h oW is h yPertension d ifferent in t yPe 2 d iAbetes M ellitus ?”
Thiazide Diuretics and β‐Blockers in the Treatment of Hypertension in Diabetes Mellitus
Sander, G. E., & Giles, T. D. (2011) · Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2011.00454.x · Cited by 15
Exploring the optimal combination therapy in hypertensive patients with diabetes mellitus
Reboldi, G., Gentile, G., Angeli, F., & Verdecchia, P. (2009) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.09.133 · Cited by 17
Effect of hypoxia on heart rate variability and baroreflex sensitivity during hypoglycemia in type 1 diabetes mellitus
Limberg, J. K., Dube, S., Kuijpers, M., Farni, K. E., Basu, A., Rizza, R. A., Curry, T. B., Basu, R., & Joyner, M. J. (2015) · Clinical Autonomic Research · doi:10.1007/s10286-015-0301-2 · Cited by 15
“Furthermore, *30 % of patients with type 1 diabetes are on anti-hypertensive medications [1], and thus the inclusion of such patient groups is clinically relevant.”
Background
Objetivos del tratamiento antihipertensivo en la población diabética. Una revisión crítica
García, F. M., Ortiz, A. G., & Alonso, M. J. M. (2004) · Medicina Clínica · doi:10.1016/s0025-7753(04)74315-8 · Cited by 15
Cardiovascular disease and risk factors in adults with diabetes mellitus in Hungary: a population-based study
Ulambayar, B., Ghanem, A. S., Kovács, N., Trefán, L., Móré, M., & Nagy, A. C. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1263365 · Cited by 17
Identification of the novel protein FAM172A, and its up-regulation by high glucose in human aortic smooth muscle cells
Jia (2010) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000489 · Cited by 14
“Although insulin resistance, hypertension, dyslipidemia and other risk factors certainly contribute to the progression of diabetic macroangiopathy (3-8), the exact mechanisms of these pathological processes remain to be elucidated.”
Background
The prevalence of hypertension in diabetic patients in Iran; a systematic review and meta-analysis
Motedayen, M., Sarokhani, D., Meysami, A., Jouybari, L. M., Sanagoo, A., & Dehkordi, A. H. (2018) · Journal of Nephropathology · doi:10.15171/jnp.2018.32 · Cited by 14
Glycemic control, dyslipidemia and endothelial dysfunction in coexisted diabetes, hypertension and nephropathy.
Shahid, S. M., Nawab, S. N., Shaikh, R., & Mahboob, T. (2012) · PubMed · Cited by 14
Relation between cardiovascular complications and blood pressure/blood glucose control in diabetic patients with hypertension receiving long-term candesartan cilexetil therapy: Challenge-DM study
Kawamori, R., Fujita, T., Matsuoka, H., Umemura, S., & Saitō, Y. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.11.011 · Cited by 14
“[10] C.”
Background
The consequences of failure to achieve targets of guidelines for prevention and treatment of diabetic complications in patients with type 1 diabetes
Lithovius, R., Harjutsalo, V., Forsblom, C. M., Saraheimo, M., & Groop, P. (2014) · Acta Diabetologica · doi:10.1007/s00592-014-0595-x · Cited by 14
“Although the pathogenesis of DN is not completely understood, it has repeatedly been shown that aggressive treatment of the hypertension, especially with ACE inhibitors and angiotensin receptor blockers, does improve the prognosis of the patients with DN [22–25].”
Background
Protective Effect of Dark Chocolate on Cardiovascular Disease Factors and Body Composition in Type 2 Diabetes: A Parallel, Randomized, Clinical Trial
Ayoobi, N., Jafarirad, S., Haghighizadeh, M. H., & Jahanshahi, A. (2017) · Iranian Red Crescent Medical Journal · doi:10.5812/ircmj.21644 · Cited by 14
Effects of diabetes on the vascular system: current research evidence and best practice recommendations
Gordon, P. A. (2004) · Journal of Vascular Nursing · doi:10.1016/s1062-0303(03)00083-9 · Cited by 15
The many faces of hypertension in individuals with type 1 diabetes
Lithovius, R., & Groop, P. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110564 · Cited by 15
Dyslipidaemia Associated with Type 2 Diabetics with Micro and Macrovascular Complications among Ghanaians
Adinortey, M. B., Gyan, B., Adjimani, J. P., Nyarko, P. E., Sarpong, C., Tsikata, F. Y., & Nyarko, A. K. (2011) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-010-0101-3 · Cited by 13
“In this study, the high TC/HDL-C ratio in the diabetics with complications compared to those without is consistent with known trends that high TC/HDL ratio indicates risk for CAD while a low TC/HDL-C indicates a low risk for CAD [34].”
Background
Hypertension Attenuates the Efficacy of Hypoglycemic Therapy for Preserving Coronary Flow Reserve in Patients with Type 2 Diabetes.
Takiuchi, S., Rakugi, H., Masuyama, T., Ikegami, H., Nishikage, T., Shintani, M., Komai, N., Nagai, M., Kamide, K., Higaki, J., et al. (2002) · Hypertension Research · doi:10.1291/hypres.25.893 · Cited by 13
“Very recent clinical reports on blood pressure control in patients with diabetes mellitus by the American Diabetes Association recommended that an aggressive blood pressure-lowering target of <130/80 mmHg should be considered for delaying the onset of diabetic macro- and microvascular complications (31).”
Background
Alagebrium (ALT-711) improves the anti-hypertensive efficacy of nifedipine in diabetic-hypertensive rats
Zhang, B., He, K., Chen, W., Cheng, X., Cui, H. Z., Wu, Z., Li, S., & Wang, L. (2014) · Hypertension Research · doi:10.1038/hr.2014.98 · Cited by 13
Clinical Outcomes in Antihypertensive Treatment of Type 2 Diabetes, Impaired Fasting Glucose Concentration, and Normoglycemia: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
Whelton, P. K., Barzilay, J. I., & Cushman, W. C. (2005) · ACC Current Journal Review · doi:10.1016/j.accreview.2005.08.200 · Cited by 13
Evaluación y control de los hipertensos diabéticos atendidos en centros de Atención Primaria de España. Estudio BRAND II
Alemán, J. A., Prieto-Díaz, M. Á., Hernández, M. L., Galindo, S. B., Iserte, A. D. L. S., Claros, N. M., & Romanos, F. G. (2011) · Atención Primaria · doi:10.1016/j.aprim.2010.05.016 · Cited by 12
The Role of Angiotensin Receptor Blockers in Diabetic Nephropathy
Sharma, A. M., & Weir, M. R. (2011) · Postgraduate Medicine · doi:10.3810/pgm.2011.05.2289 · Cited by 12
Common Drug Pathways and Interactions
Kroner, B. A. (2002) · Diabetes Spectrum · doi:10.2337/diaspect.15.4.249 · Cited by 12
An Olmesartan Medoxomil-Based Treatment Algorithm is Effective in Achieving 24-Hour BP Control in Patients with Type 2 Diabetes Mellitus, Regardless of Age, Race, Sex, or Severity of Hypertension
Neutel, J. M., & Kereiakes, D. J. (2010) · American Journal of Cardiovascular Drugs · doi:10.2165/11584690-000000000-00000 · Cited by 12
Recidivism to uncontrolled blood pressure in patients with previously controlled hypertension
Sandhu, A., Ho, P. M., Asche, S. E., Magid, D. J., Margolis, K. L., Sperl‐Hillen, J. M., Rush, B., Price, D. W., Ekstrom, H. L., Tavel, H. M., et al. (2015) · American Heart Journal · doi:10.1016/j.ahj.2015.03.012 · Cited by 12
Targeting Imd pathway receptor in Drosophila melanogaster and repurposing of phyto-inhibitors: structural modulation and molecular dynamics
Satapathy, P., Prakash, J. K., Gowda, V. C., More, S. S., Muthuchelian, K., Chandramohan, V., & Zameer, F. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1831611 · Cited by 12
“Captopril (CAP) (Arauz-Pacheco et al., 2002), a widely used drugs for treatment, is used as standard.”
Background
Initial Combination Therapy Compared With Monotherapy in Diabetic Hypertensive Patients
Sowers, J. R., Lastra, G., Rocha, R., Seifu, Y., Crikelair, N., & Levy, D. G. (2008) · Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2008.00003.x · Cited by 12
Prevalence, Awareness, and Treatment of Hypertension in Patients with Type 1 Diabetes: A Nationwide Multicenter Study in Brazil
Gomes, M. B., Tannus, L. R. M., Matheus, A. S. D. M., Cobas, R. A., Palma, C. C. S., Silva, A. T. K., Negrato, C. A., Dib, S. A., Rodacki, M., Felício, J. S., et al. (2013) · International Journal of Hypertension · doi:10.1155/2013/565263 · Cited by 11
Comparative evaluation of spironolactone, atenolol, metoprolol, ramipril and perindopril on diabetes-induced cardiovascular complications in type 1 diabetes in rats
Goyal, B. R., Bhadada, S. V., & Patel, M. M. (2019) · International Journal of Diabetes and Metabolism · doi:10.1159/000497705 · Cited by 11
Effect of Lercanidipine on Kidney Microanatomy in Cohen-Rosenthal Diabetic Hypertensive Rats
Rosenthal, T., Rosenmann, E., Tomassoni, D., & Amenta, F. (2007) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248407300621 · Cited by 10
Prevalence of microvascular complications among diabetic patients
Zia, I. (2004) · Cited by 10
The simultaneous quantification of Sitagliptin and Irbesartan in rat plasma using the validated LC-MS/MS method is applied to a pharmacokinetic study
Bhargavi, P. D., Lolla, S., Sugunan, S., Gubbiyappa, K. S., Khan, A. A., Alanazi, A. M., & Nayak, B. V. (2023) · Journal of Chromatography B · doi:10.1016/j.jchromb.2023.123677 · Cited by 10
KCNQ1 variants associate with hypertension in type 2 diabetes and affect smooth muscle contractility in vitro
Huang, K., Li, T., Liu, X., Chen, J., Chien, W.-K., Shiao, Y., Tsang, H., Lin, T., Liao, C., Huang, S., et al. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.25775 · Cited by 10
Optimizing Antidiabetic Treatment Options for Patients with Type 2 Diabetes Mellitus and Cardiovascular Comorbidities
Malesker, M. A. (2008) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.28.2.193 · Cited by 10
DiaVis: Exploration and Analysis of Diabetes through Visual Interactive System
Rahman, M., Islam, M. R., Akter, S., Prome, S. A., Islam, L., & Xu, G. (2021) · Human-Centric Intelligent Systems · doi:10.2991/hcis.k.211025.001 · Cited by 9
“Additionally, diabetes-related comorbidities such as retinopathy and nephropathy are more frequent in hypertensive diabetic patients [3,4].”
Background
Elective percutaneous coronary intervention: the relationship between preprocedural blood glucose levels and periprocedural myocardial injury.
Madani, M., Alizadeh, K., Ghazaee, S. P., Zavarehee, A., Abdi, S., Shakerian, F., Salehi, N., & Firouzi, A. (2013) · Europe PMC (PubMed Central) · Cited by 9
A Randomized Controlled Trial of an Automated Telephone Intervention to Improve Blood Pressure Control
Harrison, T. N., Ho, T. S., Handler, J., Kanter, M. H., Goldberg, R. A., & Reynolds, K. (2013) · Journal of Clinical Hypertension · doi:10.1111/jch.12162 · Cited by 9
Hypertension management in diabetic patients: prescribing trends from 1999 to 2005 in three Japanese university hospitals
Kamijima, Y., Ooba, N., Yagame, M., Samizo, K., Shimodozono, Y., Kageyama, S., Horiguchi, S., Nagai, R., Kusunoki, T., & Kubota, K. (2008) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1609 · Cited by 9
“Patients with both hypertension and diabetes mellitus are also at increased risk of microvascular complications including retinopathy and nephropathy.(7,8) Antihypertensive therapy is therefore very important in the treatment of diabetic patients who also have hypertension.”
Background
Self-Reported Health Beliefs, Lifestyle and Health Behaviours in Community-Based Patients with Diabetes and Hypertension
Lawson, B. J., Aarsen, K. V., Latter, C., Putnam, W., Natarajan, N., & Burge, F. (2011) · Canadian Journal of Diabetes · doi:10.1016/s1499-2671(11)80004-3 · Cited by 10
Cardiovascular Disease Risk Factors
Wadwa, R. P., Urbina, E. M., & Daniels, S. R. (2008) · CRC Press eBooks · doi:10.3109/9781420047981-16 · Cited by 9
Pharmacotherapy of Diabetes Mellitus: Implications for the Prevention and Treatment of Cardiovascular Disease
Ragucci, E., Zonszein, J., & Frishman, W. H. (2003) · Heart Disease · doi:10.1097/01.hdx.0000050411.62103.f5 · Cited by 9
Cardiovascular Risk Factors in Hypertension: Rationale and Design of Studies to Investigate the Effects of Controlled-Release Carvedilol on Regression of Left Ventricular Hypertrophy and Lipid Profile
Bakris, G. L., Tarka, E. A., Waterhouse, B. R., Goulding, M. R., Madan, A., & Anderson, K. M. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.08.002 · Cited by 9
A Survey of Actual Clinical Practice Concerning Blood Pressure Control among Patients with Hypertension in Kanagawa 2014
Hatori, N., Sakai, H., Sato, K., Miyajima, M., Yuasa, S., Kuboshima, S., Kajiwara, K., Hara, Y., Minamizawa, K., & Miyakawa, M. (2016) · Journal of Nippon Medical School · doi:10.1272/jnms.83.188 · Cited by 8
Relationship between Glycosylated Hemoglobin, Serum Nitric Oxide and Mean Arterial Blood Pressure
Manju, M., Vinod, R., Mishra, S., Toora, B. D., & Vijayakumar, V. (2014) · International Journal of Biomedical Science · doi:10.59566/ijbs.2014.10252 · Cited by 8
Inhibition of notch signalling and mesangial expansion by combined glucagon like peptide-1 agonist and crocin therapy in animal model of diabetic nephropathy
Amin, S. N., El-Gamal, E. M., Rashed, L. A., Kamar, S. S., & Haroun, M. A. (2020) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2020.1846203 · Cited by 8
Cardiovascular risk factors and their management in 1282 adult people with type 1 diabetes
Syed, A., Hussain, S., Nightingale, P., De, P., Charlton, M., Gangopadhyay, K. K., Barnett, A. H., & Narendran, P. (2007) · Current Medical Research and Opinion · doi:10.1185/030079907x233313 · Cited by 7
Factors associated with diabetes outpatient use of tertiary or general hospitals as their usual source of care in Korea
Lee, J. C., Kim, K. H., Kim, H. N., & Kim, N. S. (2012) · Journal of Korean Medical Association · doi:10.5124/jkma.2012.55.12.1215 · Cited by 8
“일반적으로 당뇨병 환자의 20-60%에서 고혈압이 동반되 는 것으로 알려져 있다[28].”
Perindopril and candesartan comparative efficacy and safety in type II diabetic hypertensive patients
Derosa, G., Cicero, A. F. G., Mugellini, A., Ciccarelli, L., & Fogari, R. (2003) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001572 · Cited by 8
A novel approach to treatment of hypertension in diabetic patients – a multicenter, double-blind, randomized study comparing the efficacy of combination therapy of Eprosartan versus Ramipril with low-dose Hydrochlorothiazide and Moxonidine on blood pressure levels in patients with hypertension and associated diabetes mellitus type 2 – rationale and design [ISRCTN55725285]
Pater, C., Bhatnagar, D., Berrou, J., Luszick, J. H., & Beckmann, K. (2004) · Current Controlled Trials in Cardiovascular Medicine · doi:10.1186/1468-6708-5-9 · Cited by 8
Non-communicable disease comorbidities in KwaZulu-Natal Province, South Africa
Kushitor, S. B., Sanuade, O. A., Baatiema, L., Kushitor, M. K., Afrifa-Anane, E. K., & Awuah, R. B. (2021) · South African Medical Journal · doi:10.7196/samj.2021.v111i2.14744 · Cited by 7
“[18-20] Although diabetes and hypertension are the most common NCDs (40 - 60%),[21,22] the extent of their coexistence in KZN is unknown.”
Background
Management of hypertension and diabetes: Treatment goals, drug choices, current practice, and strategies for improving care
Borzecki, A. M., & Berlowitz, D. R. (2005) · Current Hypertension Reports · doi:10.1007/s11906-005-0039-7 · Cited by 7
Early blood pressure alterations are associated with pro-inflammatory markers in type 1 diabetes mellitus
Mateo-Gavira, I., Vílchez-López, F. J., García-Palacios, M. V., Laureano, F. C. S., Visiedo, F., & Aguilar‐Diosdado, M. (2016) · Journal of Human Hypertension · doi:10.1038/jhh.2016.56 · Cited by 7
Structural modulation of dual oxidase (Duox) in Drosophila melanogaster by phyto-elicitors: A free energy study with molecular dynamics approach
Satapathy, P., Prakash, J. K., More, S. S., Chandramohan, V., & Zameer, F. (2021) · Informatics in Medicine Unlocked · doi:10.1016/j.imu.2021.100811 · Cited by 7
Diabetes in Pregnancy
Moore, T. R., & Catalano, P. M. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-4224-2.50049-1 · Cited by 7
Efficacy and Tolerability of Long-Term Rilmenidine Treatment in Hypertensive Diabetic Patients
Meredith, P., & Reid, J. L. (2004) · American Journal of Cardiovascular Drugs · doi:10.2165/00129784-200404030-00006 · Cited by 7
Diabetes Mellitus and Hypertension: A Mandate for Intense Treatment According to New Guidelines
Prisant, L. M. (2003) · American Journal of Therapeutics · doi:10.1097/00045391-200309000-00009 · Cited by 7
“The blood pressure treatment goal for hypertensive diabetic patients is less than 130/80 mmHg.(27,28) These FIGURE 4.”
BackgroundMethod
Management of Hypertension in Patients with Diabetes
Levesque, C. A. (2012) · Critical Care Nursing Clinics of North America · doi:10.1016/j.ccell.2012.11.008 · Cited by 6

Authors: Arauz-Pacheco, C., Parrott, M. A., & Raskin, P.
Affiliations: George Washington University (US)
Venue: Diabetes Care
Publisher: American Diabetes Association
Published: 2002-01-01
Volume: 25
Issue: 1
Pages: 134-147
ISSN: 0149-5992 (ISSN-L)
1935-5548
DOI: 10.2337/diacare.25.1.134
OpenAlex: W2138299277
Cited by: 326
References: 129
Citations by year: 2026: 2 · 2025: 1 · 2024: 5 · 2023: 5 · 2022: 4 · 2021: 7 · 2020: 11 · 2019: 8 · 2018: 4 · 2017: 14 · 2016: 14 · 2015: 15 · 2014: 16 · 2013: 12 · 2012: 19
FWCI: 4.04
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Diabetes Care (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords: hypertension, diabetes mellitus, antihypertensive therapy, blood pressure control, diabetic nephropathy, diabetic retinopathy, cardiovascular complications, microvascular complications, antihypertensive drug classes
MeSH terms: Adult, Diabetic Angiopathies, Female, Humans, Hypertension, Lactation, Pregnancy, Pregnancy in Diabetics, Prevalence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The Treatment of Hypertension in Adult Patients With Diabetes

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks